BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falvey S, Shipman L, Ilowite N, Beukelman T. Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2017;15:52. [PMID: 28629458 DOI: 10.1186/s12969-017-0180-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Glaser D, Torok KS. Evaluation and Treatment of Pediatric Localized Scleroderma: Pearls and Updates. Curr Treat Options in Rheum 2021;7:1-20. [DOI: 10.1007/s40674-021-00170-5] [Reference Citation Analysis]
2 Schoemaker CG, van Dijkhuizen EHP, Vastert SJ. Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients. Pediatr Rheumatol Online J 2018;16:13. [PMID: 29448947 DOI: 10.1186/s12969-018-0229-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Case SM, Nigrovic PA. Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis. Paediatr Drugs 2022. [PMID: 35364780 DOI: 10.1007/s40272-022-00496-0] [Reference Citation Analysis]
4 Smits RM, Veldhuijzen DS, van Middendorp H, Hissink Muller PCE, Armbrust W, Legger E, Wulffraat NM, Evers AWM. Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance. Pediatr Rheumatol Online J 2020;18:12. [PMID: 32033577 DOI: 10.1186/s12969-020-0407-5] [Reference Citation Analysis]
5 Hügle B, van Dijkhuizen EHP. MTX intolerance in children and adolescents with juvenile idiopathic arthritis. Rheumatology 2020;59:1482-8. [DOI: 10.1093/rheumatology/keaa139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kyvsgaard N, Thastum M, Mikkelsen TS, Christensen AE, Herlin T. Coping strategies and anxiety in association with methotrexate-induced nausea in juvenile idiopathic arthritis. Rheumatol Int 2020;40:591-8. [PMID: 31996982 DOI: 10.1007/s00296-020-04520-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Belani PJ, Kavadichanda CG, Negi VS. Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial. Rheumatol Int 2021. [PMID: 34586472 DOI: 10.1007/s00296-021-04994-1] [Reference Citation Analysis]
8 Gil EG, Åstrøm AN, Lie SA, Rygg M, Fischer J, Rosén A, Bletsa A, Luukko K, Shi XQ, Halbig J, Frid P, Cetrelli L, Tylleskär K, Rosendahl K, Skeie MS. Dental caries in children and adolescents with juvenile idiopathic arthritis and controls: a multilevel analysis. BMC Oral Health 2021;21:417. [PMID: 34433437 DOI: 10.1186/s12903-021-01758-y] [Reference Citation Analysis]
9 Crayne CB, Beukelman T. Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis. Pediatr Clin North Am 2018;65:657-74. [PMID: 30031492 DOI: 10.1016/j.pcl.2018.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
10 Kearsley-Fleet L, Vicente González L, Steinke D, Davies R, De Cock D, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL; Biologics for Children with Rheumatic Diseases (BCRD) Study and the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN). Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2019:kez048. [PMID: 30851113 DOI: 10.1093/rheumatology/kez048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
11 Mehta RS, Taylor ZL, Martin LJ, Rosen MJ, Ramsey LB. SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease. Clin Transl Sci 2021. [PMID: 34423897 DOI: 10.1111/cts.13130] [Reference Citation Analysis]
12 Vijaykumar D, Dhir V, Jain S, Pai V, Kaur J, Naidu GS, Sharma A, Khanna Sharma S, Jain S. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire. Int J Rheum Dis 2021;24:1294-301. [PMID: 34432365 DOI: 10.1111/1756-185X.14207] [Reference Citation Analysis]
13 Halyabar O, Mehta J, Ringold S, Rumsey DG, Horton DB. Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature. Paediatr Drugs 2019;21:469-92. [PMID: 31673960 DOI: 10.1007/s40272-019-00362-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]